81 FR 1208 - Manufacturer of Controlled Substances Registration: Alltech Associates, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 81, Issue 6 (January 11, 2016)

Page Range1208-1209
FR Document2016-00216

Alltech Associates, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Alltech Associates, Inc. registration as a manufacturer of those controlled substances.

Federal Register, Volume 81 Issue 6 (Monday, January 11, 2016)
[Federal Register Volume 81, Number 6 (Monday, January 11, 2016)]
[Notices]
[Pages 1208-1209]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-00216]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Alltech 
Associates, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Alltech Associates, Inc. applied to be registered as a 
manufacturer of certain basic classes of controlled substances. The 
Drug Enforcement Administration (DEA) grants Alltech Associates, Inc. 
registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated August 10, 2015, and 
published in the Federal Register on August 18, 2015, 80 FR 50041, 
Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, Illinois 60015 
applied to be registered as a manufacturer of certain basic classes of 
controlled substances. No comments or objections were submitted for 
this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Alltech Associates, Inc. to 
manufacture the basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
               Controlled substance                       Schedule
------------------------------------------------------------------------
Methcathinone (1237).............................  I
N-Ethylamphetamine (1475)........................  I
N,N-Dimethylamphetamine (1480)...................  I
4-Methylaminorex (cis isomer) (1590).............  I
Gamma Hydroxybutyric Acid (2010).................  I
Alpha-ethyltryptamine (7249).....................  I
Lysergic acid diethylamide (7315)................  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-  I
 T-7) (7348).
Tetrahydrocannabinols (7370).....................  I
Mescaline (7381).................................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).......  I
4-Methyl-2,5-dimethoxyamphetamine (7395).........  I
2,5-Dimethoxyamphetamine (7396)..................  I
2,5-Dimethoxy-4-ethylamphetamine (7399)..........  I
3,4-Methylenedioxyamphetamine (7400).............  I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (7405).........  I
4-Methoxyamphetamine (7411)......................  I
5-Methoxy-N-N-dimethyltryptamine (7431)..........  I
Alpha-methyltryptamine (7432)....................  I

[[Page 1209]]

 
Bufotenine (7433)................................  I
Diethyltryptamine (7434).........................  I
Dimethyltryptamine (7435)........................  I
Psilocybin (7437)................................  I
Psilocyn (7438)..................................  I
5-Methoxy-N,N-diisopropyltryptamine (7439).......  I
N-Ethyl-1-phenylcyclohexylamine (7455)...........  I
1-(1-Phenylcyclohexyl)pyrrolidine (7458).........  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).....  I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)  I
 (7509).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) (7517).  I
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)   I
 (7518).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl)           I
 ethanamine (2C-T-4) (7532).
Dihydromorphine (9145)...........................  I
Heroin (9200)....................................  I
Normorphine (9313)...............................  I
Methamphetamine (1105)...........................  II
1-Phenylcyclohexylamine (7460)...................  II
Phencyclidine (7471).............................  II
Phenylacetone (8501).............................  II
1-Piperidinocyclohexanecarbonitrile (8603).......  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Dihydrocodeine (9120)............................  II
Ecgonine (9180)..................................  II
Meperidine intermediate-B (9233).................  II
Morphine (9300)..................................  II
Noroxymorphone (9668)............................  II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical applications only in clinical, toxicological, and 
forensic laboratories and for distribution to its customers.

    Dated: January 4, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-00216 Filed 1-8-16; 8:45 am]
 BILLING CODE 4410-09-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of registration.
FR Citation81 FR 1208 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR